Cells for Cells Competitors and Similar CompaniesClear all

Cells for Cells's competitors and similar companies include InGeneron, Camurus, Melinta Therapeutics and Heron Therapeutics.
Cells for Cells
Cells for Cells
Cells for Cells is a biotechnology company dedicated to the research, development, and commercialization of cellular therapies.
InGeneron
InGeneron
InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells.
Camurus
Camurus
Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions.
Melinta Therapeutics
Melinta Therapeutics
Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics is a biotechnology company engaged in drug discovery and development.
Founding Date
Founding Date
2010
Founding Date
2006
Founding Date
1991
Founding Date
2000
Founding Date
1983
Type
Type
Private
Type
Private
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Las Condes, CL HQ
Locations
Houston, US HQ
München, DE
Locations
Lund, SE HQ
Sydney, AU
Mannheim, DE
Duxford, GB
Locations
Morristown, US HQ
New Haven, US
Locations
San Diego, US HQ
Employees
Employees
224% decrease
Employees
22
Employees
2182% increase
Employees
1551% decrease
Employees
20333% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
3.6 b
Valuation ($)
N/A
Valuation ($)
498.7 m
Twitter followers
Twitter followers
N/A
Twitter followers
79
Twitter followers
N/A
Twitter followers
427
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
kr1.7b (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
$127m (FY, 2023)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
kr108.4m (FY, 2023)
Cost of goods
N/A
Cost of goods
$65.1m (FY, 2023)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
kr1.6b (FY, 2023)
Gross profit
N/A
Gross profit
$61.9m (FY, 2023)
Net income
Net income
N/A
Net income
N/A
Net income
kr431.4m (FY, 2023)
Net income
N/A
Net income
($110.6m) (FY, 2023)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 23m (about 5 years ago)
Latest funding round
N/A
Latest funding round
$ 123.2m (about 6 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
$ 47.5m
Total funding raised
N/A
Total funding raised
$ 519.2m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

InGeneron
HQ
Houston, US
Employees
22

InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells.

View company
Camurus
HQ
Lund, SE
Employees
218↑ 2% increase

Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions.

View company
Melinta Therapeutics
HQ
Morristown, US
Employees
155↓ 1% decrease

Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.

View company
Heron Therapeutics
HQ
San Diego, US
Employees
203↓ 33% decrease

Heron Therapeutics is a biotechnology company engaged in drug discovery and development.

View company